Cargando…
OA08 A case of Recalcitrant Psoriatic Disease- should new treatment strategies be considered?
INTRODUCTION/BACKGROUND: Despite the advent of numerous biologic therapies and small molecular drugs targeting specific immune pathways, at least 40% of PsA patients exhibit poor response. Given the complexity and heterogeneity of signalling pathways resulting in synovio-entheseal disease in PsA; ne...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515840/ http://dx.doi.org/10.1093/rap/rkac066.008 |